Group One Trading
KYNB

Group One Trading’s Kyntra Bio KYNB Stock Holding History

Group One Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3K Sell
4,406
-86
-2% -$603 ﹤0.01% 5669
2026
Q1 		$30.5K Sell
4,492
-96
-2% -$751 ﹤0.01% 5659
2025
Q4 		$40.3K Sell
4,588
-40
-0.9% -$391 ﹤0.01% 5777
2025
Q3 		$56.7K Sell
4,628
-2,581
-36% -$24.2K ﹤0.01% 5850
2025
Q2 		$38.2K Sell
7,209
-1,277
-15% -$9.31K ﹤0.01% 5797
2025
Q1 		$65.7K Buy
8,486
+3,386
+66% +$40.6K ﹤0.01% 4938
2024
Q4 		$67.5K Buy
+5,100
New +$47.4K ﹤0.01% 4832
2024
Q3 		– Sell
-6,238
Closed -$94.1K – 6832
2024
Q2 		$139K Buy
6,238
+2,981
+92% +$92.1K ﹤0.01% 3691
2024
Q1 		$191K Buy
+3,257
New +$140K ﹤0.01% 3603
2023
Q2 		– Sell
-3,863
Closed -$1.6M – 7811
2023
Q1 		$1.8M Buy
3,863
+1,068
+38% +$565K 0.01% 1622
2022
Q4 		$1.12M Buy
2,795
+914
+49% +$350K ﹤0.01% 2312
2022
Q3 		$612K Buy
1,881
+679
+56% +$219K ﹤0.01% 3036
2022
Q2 		$317K Sell
1,202
-1,625
-57% -$415K ﹤0.01% 3865
2022
Q1 		$850K Sell
2,827
-426
-13% -$148K ﹤0.01% 3254
2021
Q4 		$1.15M Sell
3,253
-1,793
-36% -$558K ﹤0.01% 3217
2021
Q3 		$1.29M Sell
5,046
-751
-13% -$266K ﹤0.01% 3131
2021
Q2 		$3.86M Buy
5,797
+2,824
+95% +$1.63M ﹤0.01% 1945
2021
Q1 		$2.58M Sell
2,973
-23
-0.8% -$24.5K ﹤0.01% 2179
2020
Q4 		$2.78M Buy
2,996
+2,370
+379% +$2.49M ﹤0.01% 1774
2020
Q3 		$643K Sell
626
-1,122
-64% -$1.21M ﹤0.01% 2621
2020
Q2 		$1.77M Buy
1,748
+98
+6% +$91K 0.01% 1555
2020
Q1 		$1.43M Sell
1,650
-1,119
-40% -$1.11M 0.01% 1259
2019
Q4 		$2.97M Buy
2,769
+833
+43% +$850K 0.02% 986
2019
Q3 		$1.79M Sell
1,936
-1,844
-49% -$2.03M 0.01% 1299
2019
Q2 		$4.27M Sell
3,780
-545
-13% -$597K 0.04% 617
2019
Q1 		$5.88M Buy
4,325
+1,975
+84% +$2.68M 0.07% 358
2018
Q4 		$2.72M Buy
2,350
+1,609
+217% +$1.81M 0.02% 831
2018
Q3 		$1.13M Buy
+741
New +$1.14M 0.01% 1616
2018
Q2 		– Sell
-402
Closed -$524K – 5209
2018
Q1 		$464K Buy
402
+281
+232% +$370K ﹤0.01% 2122
2017
Q4 		$143K Sell
121
-717
-86% -$899K ﹤0.01% 3136
2017
Q3 		$1.13M Sell
838
-569
-40% -$600K 0.01% 1465
2017
Q2 		$1.14M Buy
1,407
+209
+17% +$146K 0.01% 1349
2017
Q1 		$738K Buy
1,198
+1,126
+1,564% +$686K 0.01% 1564
2016
Q4 		$38K Buy
+72
New +$36K ﹤0.01% 3408
2016
Q3 		– Sell
-407
Closed -$192K – 4639
2016
Q2 		$167K Buy
407
+51
+14% +$23.4K ﹤0.01% 2518
2016
Q1 		$190K Buy
356
+304
+585% +$151K ﹤0.01% 2351
2015
Q4 		$40K Sell
52
-986
-95% -$654K ﹤0.01% 3538
2015
Q3 		$569K Buy
1,038
+127
+14% +$76.9K 0.01% 1667
2015
Q2 		$535K Buy
+911
New +$530K 0.01% 1720

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Group One Trading's KYNB Position: Q2 2026 in Review

Group One Trading reduced its Kyntra Bio (KYNB) stake by 1.9% in Q2 2026, selling an estimated $603 and leaving 4,406 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5669.

Group One Trading first reported a position in KYNB in Q2 2015 and has held it in 39 quarters since. The position peaked at $5.88M in Q1 2019. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Group One Trading held 4,406 shares of Kyntra Bio worth $33.3K as of Q2 2026.
  • Group One Trading sold 86 Kyntra Bio shares in Q2 2026, an estimated $603.
  • Kyntra Bio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5669 holding.
  • Group One Trading first reported a position in Kyntra Bio in Q2 2015 and has held it in 39 quarters since.
  • Group One Trading's Kyntra Bio position peaked at $5.88M in Q1 2019.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.